Therapeutic Plasma Exchange Industry Overview
The therapeutic plasma exchange systems market is moderately competitive and consists of several major players. Some of the companies are expanding their market position by adopting various strategies such as acquisitions and mergers, while others are developing new methods for the treatment and introducing new products to maintain their market share. For Instance, In April 2017, Terumo BCT received the first and only CE mark approval for its Spectra Optia Apheresis System to treat Guillain-Barre syndrome (GBS) and myasthenia gravis (MG) using Therapeutic Plasma Exchange in the European Market fueling the market revenue share. Few of the major players currently dominating the industry in terms of revenue are Asahi Kasei Corporation, Baxter International Inc, Terumo Corporation, B. Braun Melsungen AG, and Fresenius Kabi AG
Therapeutic Plasma Exchange Market Leaders
-
Asahi Kasei Corporation
-
Baxter International Inc
-
Terumo Corporation
-
B. Braun Melsungen AG
-
Fresenius Kabi AG
- *Disclaimer: Major Players sorted in no particular order
